Table 5. Relative and cumulative frequencies of gene mutations.
| P (95%CI)‡ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gene | Host | Group | Setting | N | P | L | U | References |
| gyrA | Human | NTS | Cm, Ad | 94 | 77.7 | 68.2 | 84.9 | [31–34,45–49,51–54,63] |
| Human | TyS | Cm | 162 | 84 | 77.5 | 88.8 | [31,35–38,41–43,63,64] | |
| Human | NTS | Tr | 47 | 100 | 92.4 | 100 | [54–56] | |
| Animal | NTS | A/P | 33 | 60.6 | 43.7 | 75.3 | [52, 55,56,60] | |
| Overall | 336 | 82.1 | 77.7 | 85.9 | [31–38, 41–43, 45–49, 51–56,63,64] | |||
| gyrB | Human | NTS | Cm, Ad | 62 | 4.8 | 1.7 | 13.3 | [31–34,46,48,49,51,52,54,63] |
| Human | TyS | Cm | 137 | 2.2 | 0.7 | 6.2 | [31,35,36,38,41–43,63,64] | |
| Human | NTS | Tr | 47 | 0 | 0 | 7.6 | [54–56] | |
| Animal | NTS | A/P | 32 | 6.3 | 1.7 | 20.1 | [52,55,56] | |
| Overall | 278 | 2.9 | 1.5 | 5.6 | [31–36,38, 41–43, 46,48,49, 51–56,63,64] | |||
| parC | Human | NTS | Cm, Ad | 63 | 22.2 | 13.7 | 33.9 | [31–34,46,48,49,51–54,63] |
| Human | TyS | Cm, | 162 | 4.9 | 2.5 | 9.4 | [31,35–38,41–43,63,64] | |
| Human | NTS | Tr | 47 | 87.2 | 74.8 | 94 | [54–56] | |
| Animal | NTS | A/P | 33 | 54.5 | 38 | 70.2 | [52,55,56,60] | |
| Overall | 305 | 26.6 | 21.9 | 31.8 | [31–36,38,41–43,46,48,49,51–56,60,63,64] | |||
| parE | Human | NTS | Cm, Ad | 30 | 0 | 0 | 11.4 | [34,48,49,51,52,54] |
| Human | TyS | Cm | 68 | 0 | 0 | 5.3 | [36,37,38,41–43] | |
| Human | NTS | Tr | 47 | 0 | 0 | 7.6 | [54–56] | |
| Animal | NTS | A/P | 32 | 0 | 0 | 10.7 | [52,55,56] | |
| Overall | 177 | 0 | 0 | 2.1 | [34,36–38,41–43,48,49,51,52,54–56] | |||
Ad, adoptees; A/P, animals/animal products; Cm, community; P, proportion; L, lower limit; N, number; NTS, non-typhoidal Salmonella; OR, odds ratio; Tr, travel-associated; TyS, typhoidal Salmonella; U, upper limit.
‡Score confidence interval.